Human Cytomegalovirus RNA2.7 Is Required for Upregulating Multiple Cellular Genes To Promote Cell Motility and Viral Spread Late in Lytic Infection.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
27 09 2021
Historique:
pubmed: 5 8 2021
medline: 11 2 2022
entrez: 4 8 2021
Statut: ppublish

Résumé

Long noncoding RNAs (lncRNAs) are frequently associated with broad modulation of gene expression and thus provide the cell with the ability to synchronize entire metabolic processes. We used transcriptomic approaches to investigate whether the most abundant human cytomegalovirus-encoded lncRNA, RNA2.7, has this characteristic. By comparing cells infected with wild-type virus (WT) to cells infected with RNA2.7 deletion mutants, RNA2.7 was implicated in regulating a large number of cellular genes late in lytic infection. Pathway analysis indicated that >100 of these genes are associated with promoting cell movement, and the 10 most highly regulated of these were validated in further experiments. Morphological analysis and live cell tracking of WT- and RNA2.7 mutant-infected cells indicated that RNA2.7 is involved in promoting the movement and detachment of infected cells late in infection, and plaque assays using sparse cell monolayers indicated that RNA2.7 is also involved in promoting cell-to-cell spread of virus. Consistent with the observation that upregulated mRNAs are relatively A+U-rich, which is a trait associated with transcript instability, and that they are also enriched in motifs associated with mRNA instability, transcriptional inhibition experiments on WT- and RNA2.7 mutant-infected cells showed that four upregulated transcripts lived longer in the presence of RNA2.7. These findings demonstrate that RNA2.7 is required for promoting cell movement and viral spread late in infection and suggest that this may be due to general stabilization of A+U-rich transcripts.

Identifiants

pubmed: 34346763
doi: 10.1128/JVI.00698-21
pmc: PMC8475523
doi:

Substances chimiques

RNA, Long Noncoding 0
RNA, Messenger 0
RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0069821

Subventions

Organisme : Wellcome Trust
ID : 204870/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12014/12
Pays : United Kingdom
Organisme : Wellcome Trust (Wellcome)
ID : 108070/Z/15/Z
Organisme : UKRI | Medical Research Council (MRC)
ID : MR/S00971X/1
Organisme : UKRI | Medical Research Council (MRC)
ID : MC_UU_12014/3
Organisme : Medical Research Council
ID : MR/S00971X/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : HCRW_
ID : HCRW_HS-14-11
Pays : United Kingdom
Organisme : UKRI | Medical Research Council (MRC)
ID : MC_UU_12014/12
Organisme : Wellcome Trust (Wellcome)
ID : 204870/Z/16/Z
Organisme : Medical Research Council
ID : MC_UU_12014/3
Pays : United Kingdom

Références

Methods. 2017 Feb 15;115:80-90
pubmed: 27713081
J Virol. 1997 Aug;71(8):5849-60
pubmed: 9223474
Nucleic Acids Res. 2002 Dec 15;30(24):5529-38
pubmed: 12490721
Nucleic Acids Res. 2001 Jan 1;29(1):246-54
pubmed: 11125104
Med Microbiol Immunol. 2015 Jun;204(3):273-84
pubmed: 25894764
Science. 2012 Nov 23;338(6110):1088-93
pubmed: 23180859
J Virol. 2016 Mar 28;90(8):3929-43
pubmed: 26842472
Virology. 1983 Feb;125(1):31-46
pubmed: 6187127
Front Immunol. 2017 Apr 21;8:461
pubmed: 28484459
Oncotarget. 2018 Jan 1;9(26):18648-18663
pubmed: 29719633
Front Genet. 2018 Sep 27;9:432
pubmed: 30319694
Genomics. 2005 Feb;85(2):165-75
pubmed: 15676275
Viruses. 2014 Nov 04;6(11):4212-26
pubmed: 25375885
Nat Rev Genet. 2014 Jan;15(1):7-21
pubmed: 24296535
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):6104-6109
pubmed: 28533400
PLoS One. 2016 Oct 19;11(10):e0164843
pubmed: 27760232
J Virol. 1982 Feb;41(2):462-77
pubmed: 6281461
J Virol. 2004 Nov;78(22):12097-106
pubmed: 15507596
Nucleic Acids Res. 2013 Jan;41(Database issue):D983-6
pubmed: 23175614
J Virol. 1998 Dec;72(12):9924-33
pubmed: 9811729
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
Cell. 2014 Jun 5;157(6):1460-1472
pubmed: 24906157
J Virol. 2012 Sep;86(17):9369-83
pubmed: 22718829
Biotechniques. 2008 Dec;45(6):659-62, 664-8
pubmed: 19238796
Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19755-60
pubmed: 22109557
EMBO Rep. 2019 Nov 5;20(11):e48220
pubmed: 31482640
J Immunol. 2009 Jan 1;182(1):477-88
pubmed: 19109179
J Virol. 1998 Nov;72(11):8463-71
pubmed: 9765382
J Virol. 1997 Jun;71(6):4199-208
pubmed: 9151806
Eur J Cell Biol. 2011 Jun-Jul;90(6-7):545-52
pubmed: 21112119
J Gen Virol. 2004 May;85(Pt 5):1301-1312
pubmed: 15105547
J Virol. 2011 May;85(10):5150-8
pubmed: 21367908
J Neurovirol. 2013 Feb;19(1):102-8
pubmed: 23335177
J Virol. 2007 Oct;81(20):11267-81
pubmed: 17686857
Nat Protoc. 2012 Mar 01;7(3):562-78
pubmed: 22383036
Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):18971-18982
pubmed: 31481624
J Exp Med. 2012 Jan 16;209(1):1-10
pubmed: 22184634
J Virol. 2019 Aug 13;93(17):
pubmed: 31189700
Virol J. 2011 Jun 14;8:299
pubmed: 21669005
PLoS Pathog. 2011 Oct;7(10):e1002300
pubmed: 22022268
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Virol. 2013 Oct;87(19):10489-500
pubmed: 23885075
J Virol. 1989 Dec;63(12):5334-43
pubmed: 2555558
J Clin Invest. 2010 Sep;120(9):3191-208
pubmed: 20679731
Mol Cell Biol. 1995 Apr;15(4):2219-30
pubmed: 7891716
J Virol. 2001 Apr;75(7):3383-90
pubmed: 11238864
Nat Microbiol. 2019 Feb;4(2):216-225
pubmed: 30420785
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Virus Res. 1987 Feb;7(1):17-31
pubmed: 2436392
FEMS Microbiol Rev. 2012 May;36(3):684-705
pubmed: 22150699
Front Genet. 2018 Nov 06;9:524
pubmed: 30459811
Science. 2007 Jun 1;316(5829):1345-8
pubmed: 17540903
DNA Res. 2009 Feb;16(1):45-58
pubmed: 19001483
EMBO J. 2005 May 18;24(10):1831-41
pubmed: 15861127
Cell. 2006 Mar 24;124(6):1283-98
pubmed: 16564017
Mol Cell Biol. 2003 Jan;23(2):425-36
pubmed: 12509443
Front Immunol. 2019 Jun 10;10:1155
pubmed: 31244824
Front Cell Infect Microbiol. 2020 Jul 22;10:361
pubmed: 32793512
J Virol. 1998 Feb;72(2):1235-43
pubmed: 9445023
PLoS Pathog. 2020 Apr 15;16(4):e1008390
pubmed: 32294138
Genome Res. 2003 Aug;13(8):1863-72
pubmed: 12902380
Proc Natl Acad Sci U S A. 2018 May 8;115(19):4998-5003
pubmed: 29691324
iScience. 2019 Oct 25;20:60-72
pubmed: 31569051
Elife. 2019 Dec 19;8:
pubmed: 31855182
PLoS Pathog. 2013;9(5):e1003366
pubmed: 23717203
Bioinformatics. 2010 Feb 1;26(3):401-2
pubmed: 19965881
J Virol. 1985 Mar;53(3):711-8
pubmed: 2983083
J Virol. 2014 Feb;88(3):1843-8
pubmed: 24257619
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Science. 2006 Jan 20;311(5759):377-81
pubmed: 16424340
Nucleic Acids Res. 2005 Feb 24;33(4):e36
pubmed: 15731329
RNA Biol. 2014;11(2):124-33
pubmed: 24525793
Viruses. 2014 Mar 05;6(3):1049-72
pubmed: 24603756
Am J Pathol. 1992 Nov;141(5):1247-54
pubmed: 1332487
Nat Methods. 2008 Jul;5(7):621-8
pubmed: 18516045
J Virol. 2008 Apr;82(7):3654-64
pubmed: 18199641
Genome Biol. 2001;2(10):RESEARCH0041
pubmed: 11597333
mBio. 2018 Mar 13;9(2):
pubmed: 29535194
Cell. 1999 Nov 24;99(5):511-20
pubmed: 10589679
PLoS Genet. 2012 Jan;8(1):e1002433
pubmed: 22242014
Nat Struct Mol Biol. 2020 Jun;27(6):581-588
pubmed: 32451488
J Virol. 2015 Mar;89(6):3062-75
pubmed: 25552717
J Gen Virol. 1997 Aug;78 ( Pt 8):1981-92
pubmed: 9266998
Virus Genes. 2017 Aug;53(4):650-655
pubmed: 28391502
Cell Host Microbe. 2018 Sep 12;24(3):447-460.e11
pubmed: 30122656
J Virol. 2004 Oct;78(19):10390-8
pubmed: 15367605
PLoS Biol. 2006 Jun;4(6):e180
pubmed: 16700628
J Heart Lung Transplant. 2010 Mar;29(3):342-5
pubmed: 20036157
Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):790-4
pubmed: 1846963
J Gen Virol. 2003 Sep;84(Pt 9):2511-2516
pubmed: 12917473
Methods Mol Biol. 2018;1706:91-110
pubmed: 29423795
Curr Opin Virol. 2017 Oct;26:156-162
pubmed: 29031103

Auteurs

Betty Lau (B)

MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.

Karen Kerr (K)

MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.

Salvatore Camiolo (S)

MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.

Katie Nightingale (K)

Cambridge Institute for Medical Research, University of Cambridgegrid.5335.0, Cambridge, United Kingdom.

Quan Gu (Q)

MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.

Robin Antrobus (R)

Cambridge Institute for Medical Research, University of Cambridgegrid.5335.0, Cambridge, United Kingdom.

Nicolás M Suárez (NM)

MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.

Colin Loney (C)

MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.

Richard J Stanton (RJ)

Division of Infection and Immunity, Cardiff Universitygrid.5600.3 School of Medicine, Cardiff, United Kingdom.

Michael P Weekes (MP)

Cambridge Institute for Medical Research, University of Cambridgegrid.5335.0, Cambridge, United Kingdom.

Andrew J Davison (AJ)

MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH